Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry - PubMed (original) (raw)
Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry
A J Karter et al. Am J Med. 2001 Jul.
Abstract
Purpose: We sought to evaluate the effectiveness of self-monitoring blood glucose levels to improve glycemic control.
Subjects and methods: A cohort design was used to assess the relation between self-monitoring frequency (1996 average daily glucometer strip utilization) and the first glycosylated hemoglobin (HbA1c) level measured in 1997. The study sample included 24,312 adult patients with diabetes who were members of a large, group model, managed care organization. We estimated the difference between HbA1c levels in patients who self-monitored at frequencies recommended by the American Diabetes Association compared with those who monitored less frequently or not at all. Models were adjusted for age, sex, race, education, occupation, income, duration of diabetes, medication refill adherence, clinic appointment "no show" rate, annual eye exam attendance, use of nonpharmacological (diet and exercise) diabetes therapy, smoking, alcohol consumption, hospitalization and emergency room visits, and the number of daily insulin injections.
Results: Self-monitoring among patients with type 1 diabetes (> or = 3 times daily) and pharmacologically treated type 2 diabetes (at least daily) was associated with lower HbA1c levels (1.0 percentage points lower in type 1 diabetes and 0.6 points lower in type 2 diabetes) than was less frequent monitoring (P < 0.0001). Although there are no specific recommendations for patients with nonpharmacologically treated type 2 diabetes, those who practiced self-monitoring (at any frequency) had a 0.4 point lower HbA1c level than those not practicing at all (P < 0.0001).
Conclusion: More frequent self-monitoring of blood glucose levels was associated with clinically and statistically better glycemic control regardless of diabetes type or therapy. These findings support the clinical recommendations suggested by the American Diabetes Association.
Similar articles
- Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R. Karter AJ, et al. JAMA. 2021 Jun 8;325(22):2273-2284. doi: 10.1001/jama.2021.6530. JAMA. 2021. PMID: 34077502 Free PMC article. - Self-monitoring of blood glucose: language and financial barriers in a managed care population with diabetes.
Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Karter AJ, et al. Diabetes Care. 2000 Apr;23(4):477-83. doi: 10.2337/diacare.23.4.477. Diabetes Care. 2000. PMID: 10857938 - Color record in self-monitoring of blood glucose improves glycemic control by better self-management.
Nishimura A, Harashima S, Honda I, Shimizu Y, Harada N, Nagashima K, Hamasaki A, Hosoda K, Inagaki N. Nishimura A, et al. Diabetes Technol Ther. 2014 Jul;16(7):447-53. doi: 10.1089/dia.2013.0301. Epub 2014 Feb 7. Diabetes Technol Ther. 2014. PMID: 24506479 Clinical Trial. - Monitoring glycemic control: the importance of self-monitoring of blood glucose.
Renard E. Renard E. Am J Med. 2005 Sep;118(Suppl 9A):12S-19S. doi: 10.1016/j.amjmed.2005.07.052. Am J Med. 2005. PMID: 16224938 Review. - Capillary blood glucose monitoring.
Wallymahmed M. Wallymahmed M. Nurs Stand. 2007 May 30-Jun 5;21(38):35-8. doi: 10.7748/ns2007.05.21.38.35.c4561. Nurs Stand. 2007. PMID: 17569467 Review.
Cited by
- 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.
Moon JS, Kang S, Choi JH, Lee KA, Moon JH, Chon S, Kim DJ, Kim HJ, Seo JA, Kim MK, Lim JH, Song YJ, Yang YS, Kim JH, Lee YB, Noh J, Hur KY, Park JS, Rhee SY, Kim HJ, Kim HM, Ko JH, Kim NH, Kim CH, Ahn J, Oh TJ, Kim SK, Kim J, Han E, Jin SM, Bae J, Jeon E, Kim JM, Kang SM, Park JH, Yun JS, Cha BS, Moon MK, Lee BW. Moon JS, et al. Diabetes Metab J. 2024 Jul;48(4):546-708. doi: 10.4093/dmj.2024.0249. Epub 2024 Jul 26. Diabetes Metab J. 2024. PMID: 39091005 Free PMC article. No abstract available. - Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking.
Aleppo G, Hirsch IB, Parkin CG, McGill J, Galindo R, Kruger DF, Levy CJ, Forlenza GP, Umpierrez GE, Grunberger G, Bergenstal RM. Aleppo G, et al. Diabetes Technol Ther. 2023 Oct;25(10):741-751. doi: 10.1089/dia.2023.0268. Epub 2023 Aug 3. Diabetes Technol Ther. 2023. PMID: 37471068 Free PMC article. Review. - Assessing non-adjunctive CGM safety at home and in new markets (ANSHIN).
Chao C, Andrade SB, Bergford S, Calhoun P, Welsh JB, Walker TC; ANSHIN Study Group. Chao C, et al. Endocrinol Diabetes Metab. 2023 May;6(3):e414. doi: 10.1002/edm2.414. Epub 2023 Mar 2. Endocrinol Diabetes Metab. 2023. PMID: 36864014 Free PMC article. Clinical Trial. - Association of cannabis use during pregnancy with severe acute respiratory syndrome coronavirus 2 infection: a retrospective cohort study.
Young-Wolff KC, Ray GT, Alexeeff SE, Benowitz N, Adams SR, Does MB, Goler N, Ansley D, Conway A, Avalos LA. Young-Wolff KC, et al. Addiction. 2023 Feb;118(2):317-326. doi: 10.1111/add.16056. Epub 2022 Oct 12. Addiction. 2023. PMID: 36189777 Free PMC article. - Development and implementation of a prescription opioid registry across diverse health systems.
Ray GT, Altschuler A, Karmali R, Binswanger I, Glanz JM, Clarke CL, Ahmedani B, Andrade SE, Boscarino JA, Clark RE, Haller IV, Hechter R, Roblin DW, Sanchez K, Yarborough BJ, Bailey SR, McCarty D, Stephens KA, Rosa CL, Rubinstein AL, Campbell CI. Ray GT, et al. JAMIA Open. 2022 May 17;5(2):ooac030. doi: 10.1093/jamiaopen/ooac030. eCollection 2022 Jul. JAMIA Open. 2022. PMID: 35651523 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical